title: Monotherapy with α-blocker or phosphodiesterase 5 inhibitor for lower urinary tract symptoms?
authors.forename: Christopher R
authors.initials: CR
authors.lastname: Chapple
mesh_terms: D058668:Adrenergic alpha-1 Receptor Antagonists / Q000627:therapeutic use*; D002243:Carbolines / Q000627:therapeutic use*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy*; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D013449:Sulfonamides / Q000627:therapeutic use*; D000068581:Tadalafil; D000077409:Tamsulosin; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D058668:Adrenergic alpha-1 Receptor Antagonists; D002243:Carbolines; D013449:Sulfonamides; D014665:Vasodilator Agents; D000068581:Tadalafil; D000077409:Tamsulosin